Clinical Trials Logo

Clinical Trial Summary

The primary objective of this study is to evaluate the safety and effectiveness of the Surpass™ Evolve Flow Diverter System in the treatment of unruptured, wide-neck intracranial aneurysms measuring ≤ 12 mm and located on the ICA or its branches


Clinical Trial Description

The Surpass Evolve Flow Diverter System is indicated for the endovascular treatment of adults (age 18 or above) with unruptured saccular wide-neck or fusiform intracranial aneurysms ≤ 12 mm for treatment in vessel diameters between 1.75-5.0mm. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04195568
Study type Interventional
Source Stryker Neurovascular
Contact
Status Active, not recruiting
Phase N/A
Start date July 7, 2020
Completion date September 13, 2028

See also
  Status Clinical Trial Phase
Recruiting NCT03117803 - The Natural Course of Unruptured Intracranial Aneurysms in a Chinese Cohort N/A
Terminated NCT05544045 - China Surpass Streamline Post-Market Study
Not yet recruiting NCT02820779 - New Covered Stent (Willis) for the Endovascular Reconstruction of Intracranial Vessel Wall Defects Registry N/A
Withdrawn NCT04886505 - An EFS Assessing the Electrolytic eCLIPs System for Treatment of Intracranial Aneurysms N/A
Recruiting NCT05029947 - Setting Benchmarks for Microsurgical Clipping of Unruptured Intracranial Aneurysms
Recruiting NCT04852783 - US IDE Study of the Contour NEurovasCular System™ for IntraCranial Aneurysm Repair Phase 4
Completed NCT02354300 - Transcranial Doppler Ultrasound Monitoring During Flow-Diverter Embolization N/A